Hemoglobin A1c as a prognostic marker in patients undergoing primary angioplasty for acute myocardial infarction

Coronary Artery Disease

Volumn 22, Issue 3, 2011, Pages 131-137

  Cicek, Gokhan ^a   Uyarel, Huseyin ^c   Ergelen, Mehmet ^c   Ayhan, Erkan ^a   Abanonu, Gul Babacan ^b   Eren, Mehmet ^a   Gibson, Charles Michael ^d  

^a Siyami Ersek Cardiovascular and Thoracic Surgery Center   (Turkey)

^b Haydarpa a Numune Research and Education Hospital   (Turkey)

^c BALIKESIR UNIVERSITY   (Turkey)

^d HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Acute myocardial infarction; diabetes mellitus; hemoglobin A1c; primary angioplasty

Indexed keywords

HEMOGLOBIN A1C;

ADULT; AORTA BALLOON; ARTICLE; ATRIOVENTRICULAR BLOCK; BLOOD SAMPLING; CARDIOGENIC SHOCK; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; FOLLOW UP; HEART ATRIUM FIBRILLATION; HEART REINFARCTION; HEART VENTRICLE ARRHYTHMIA; HOSPITALIZATION; HUMAN; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; MORTALITY; PERCUTANEOUS CORONARY INTERVENTION; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; RESUSCITATION; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; STENT THROMBOSIS; STROKE;

ADULT; AGED; ANGIOPLASTY, BALLOON, CORONARY; BIOLOGICAL MARKERS; DIABETES MELLITUS; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HOSPITAL MORTALITY; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PROGNOSIS; PROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 79955074077     PISSN: 09546928     EISSN: None     Source Type: Journal    
DOI: 10.1097/MCA.0b013e328342c760     Document Type: Article

References (23)

1. Miettinen H, Lehto S, Salomaa V, Mahonen V, Niemela M, Haffner SM, et al.; for the FINMONICA Myocardial Infarction Register Study Group. Impact of diabetes on mortality after the first myocardial infarction. Diabetes Care 1998; 21:69-75. (Pubitemid 28030388)
2. American Diabetes Association. Standards of medical care in diabetes 2010. Diabetes Care 2010; 33 (Suppl 1):S11-S61.
3. Jeffcoate SL. Diabetes control and complications: the role of glycated hemoglobin, 25 years on. Diabet Med 2004; 21:657-665. (Pubitemid 38916208)
4. Tenerz A, Nilsson G, Forberg R, Ohrvik J, Malmberg K, Berne C, Leppert J. Bazal glucometabolic status has an impact on long-term prognosis following an acute myocardial infarction in non-diabetic patients. J Intern Med 2003; 254:494-503. (Pubitemid 37346634)
5. Malmberg K, Ryden L,Wedel H, Birkeland K, Bootsma A, Dickstein K, et al.; DIGAMI 2 Investigators. Intense metabolic control by means of insulin in patients with diabetes mellitus and acute myocardial infarction (DIGAMI 2): effects on mortality and morbidity. Eur Heart J 2005; 26:650-661. (Pubitemid 40516876)
6. Schiller NB, Shah PM, Crawford M, DeMaria A, Devereux R, Feigenbaum H, et al. Recommendations for quantitation of the left ventricle by twodimensional echocardiography: American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two- Dimensional Echocardiograms. J Am Soc Echocardiogr 1989; 2:358-367.
7. Chesebro JH, Knatterud G, Roberts R, Borer J, Cohen LS, Dalen J, et al. Thrombolysis in Myocardial Infarction (TIMI) Trial, Phase I: a comparison between intravenous tissue plasminogen activator and intravenous streptokinase. Clinical findings through hospital discharge. Circulation 1987; 76:142-154.
8. Killip T, Kimball JT. Treatment of myocardial infarction in a coronary care unit: a two-year experience with 250 patients. Am J Cardiol 1967; 20:457-464.
9. Goldstein DE, Little RR, Lorenz RA, Malone JI, Nathan D, Peterson CM. American Diabetes Association technical review on tests of glycemia. Diabetes Care 1995; 18:896-909.
10. Kim K-S, Kim S-K, Lee Y-K, Park S-W, Cho Y-W. Diagnostic value of glycated hemoglobin (HbA1c) for the early detection of diabetes in high-risk subjects. Diabet Med 2008; 25:997-1000.
11. Hadjadj S, Coisne D, Mauco G, Ragot S, Duengler F, Sosner P, et al. Prognostic value of admission plasma glucose and HbA in acute myocardial infarction. Diabet Med 2004; 21:305-310. (Pubitemid 38519663)
12. Vistisen D, Colagiuri S, Borch-Johnsen K; The DETECT-2 Collaboration. Bimodal distribution of glucose is not universally useful for diagnosing diabetes. Diabetes Care 2009; 32:397-403.
13. Sabanayagam C, Liew G, Tai ES, Shankar A, Lim SC, Subramaniam T,Wong TY. Relationship between glycated hemoglobin and microvascular complications: is there a natural cut-off point fort he diagnosis of diabetes. Diabetologia 2009; 52:1279-1289.
14. Ergelen M, Uyarel H, Cicek G, Isik T, Osmonov D, Gunaydin ZY, et al. Which is worst in patients undergoing primary angioplasty for acute myocardial infarction? Hyperglycaemia? Diabetes mellitus? Or both? Acta Cardiol 2010; 65:415-423.
15. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 2010; 33 (Suppl 1):S62-S69.
16. Stratton IM, Adler AI, Neil HA, Yudkin JS, Matthews DR, Cull CA, et al. Association of glycaemic control with macrovascular and microvascular complications of type 2 diabetes (UKPDS 36): prospective observational study. BMJ 2000; 321:405-412. (Pubitemid 30609442)
17. Corpus RA, O'Neill WW, Dixon SR, Timmis GC, Devlin WH. Relation of hemoglobin A1c to rate of major adverse cardiac events in nondiabetic patients undergoing percutaneous coronary revascularization. Am J Cardiol 2003; 92:1282-1286. (Pubitemid 37431135)
18. Cao JJ, Hudson M, Jankowski M, Whitehouse F, Weaver D. Relation of chronic and acute glycemic control on mortality in acute myocardial infarction with diabetes mellitus. Am J Cardiol 2005; 96:183-186. (Pubitemid 40978570)
19. Timmer JR, Ottervanger JP, Bilo HJG, Dambrink JHE, Miedema K, Hoorntje JCA, Zijlstra F. Prognostic value of admission glucose and glycosylated hemoglobin levels in acute coronary syndromes. Q J Med 2006; 99:237-243.
20. Gustafsson I, Kistorp CN, James MK, Faber JO, Dickstein K, Hildebrandt Per R; For the OPTIMAAL Study Group. Unrecognized glycometabolic disturbance as measured by hemoglobin A1c is associated with a poor outcome after acute myocardial infarction. Am Heart J 2007; 154:470-476. (Pubitemid 47268241)
21. Malmberg K, Norhammar A, Wedel H, Ryden L. Glycometabolic state at admission: important risk marker of mortality in conventionally treated patients with diabetes mellitus and acute myocardial infarction: long-term results from the Diabetes and Insulin-Glucose Infusion in Acute Myocardial Infarction (DIGAMI) study. Circulation 1999; 99:2626-2632. (Pubitemid 29237448)
22. Gustafsson F, Kragelund CB, Torp-Pedersen C, Seibaek M, Burchardt H, Akkan D, et al.; DIAMOND Study Group. Effect of obesity and being overweight on long-term mortality in congestive heart failure: influence of left ventricular systolic function. Eur Heart J 2005; 26:58-64. (Pubitemid 40221124)
23. Chowdhury TA, Lasker SS. Elevated glycosylated hemoglobin in nondiabetic patients is associated with an increased mortality in myocardial infarction. Postgrad Med J 1998; 74:480-481. (Pubitemid 28408542)